- Verifica M 50/850 mg Tablet effectively lowers blood sugar levels in patients with Type 2 diabetes.
- This formulation helps improve insulin sensitivity, making it easier for the body to utilize glucose.
- Verifica M 50/850 mg Tablet aids in reducing hepatic glucose production, contributing to better glycemic control.
- Patients using Verifica M 50/850 mg Tablet may experience fewer episodes of hypoglycemia compared to other diabetes medications.
- Verifica M 50/850 mg Tablet supports weight management, which is beneficial for individuals with Type 2 diabetes.
- This medication can be used in conjunction with diet and exercise to enhance overall diabetes management.
- Verifica M 50/850 mg Tablet is suitable for adults who require additional glycemic control beyond monotherapy.
- Regular use of Verifica M 50/850 mg Tablet can help prevent long-term complications associated with uncontrolled diabetes.
- Verifica M 50/850 mg Tablet is often prescribed when other medications have not achieved desired blood sugar levels.
- This combination therapy is designed to provide comprehensive management of Type 2 diabetes.
- Verifica M 50/850 mg Tablet can improve overall metabolic health by addressing insulin resistance.
- Patients may find that Verifica M 50/850 mg Tablet enhances their quality of life by stabilizing energy levels throughout the day.
Verifica M 50/850 mg Tablet - Strip of 15
Compositions : Vildagliptin 50mg + Metformin 850mg
MRP :
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Lupin Limited
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Verifica M 50/850 mg Tablet is a specialized pharmaceutical formulation designed for the management of Type 2 diabetes mellitus. This medication combines two active ingredients, Metformin and Vildagliptin, which work synergistically to control blood sugar levels effectively. The key composition of Verifica M 50/850 mg Tablet includes 50 mg of Vildagliptin and 850 mg of Metformin, making it a potent option for patients struggling with diabetes management. The primary purpose of Verifica M 50/850 mg Tablet is to improve glycemic control in adults with Type 2 diabetes, particularly when diet and exercise alone are insufficient. As part of the therapeutic category of antidiabetic medications, Verifica M 50/850 mg Tablet plays a crucial role in enhancing insulin sensitivity and reducing hepatic glucose production. By incorporating Verifica M 50/850 mg Tablet into their treatment regimen, patients can experience better overall health outcomes and a reduced risk of diabetes-related complications. This combination therapy not only helps in managing blood sugar levels but also supports weight management, making it an ideal choice for many individuals with Type 2 diabetes. The unique formulation of Verifica M 50/850 mg Tablet allows for improved patient adherence due to its once-daily dosing schedule, which simplifies the treatment process. Overall, Verifica M 50/850 mg Tablet represents a significant advancement in diabetes care, providing patients with an effective tool to manage their condition and improve their quality of life.
Product Details
Verifica M 50/850 mg Tablet works through a dual mechanism of action that targets different aspects of glucose metabolism. The combination of Metformin and Vildagliptin provides a comprehensive approach to managing blood sugar levels effectively.
- Metformin decreases hepatic glucose production, which helps lower blood sugar levels.
- This medication enhances insulin sensitivity in peripheral tissues, allowing for better glucose uptake.
- Vildagliptin increases the levels of incretin hormones, which stimulate insulin secretion in response to meals.
- The formulation reduces glucagon secretion, further aiding in blood sugar regulation.
- By combining these two mechanisms, Verifica M 50/850 mg Tablet provides more effective glycemic control than either drug alone.
- This dual-action approach minimizes the risk of hypoglycemia while promoting weight stability.
- Verifica M 50/850 mg Tablet should be taken orally with food to minimize gastrointestinal discomfort.
- The recommended dosage is typically one tablet daily, but this may vary based on individual needs and physician recommendations.
- It is essential to take Verifica M 50/850 mg Tablet at the same time each day to maintain consistent blood sugar control.
- Patients should follow their healthcare provider's instructions regarding dosage adjustments based on blood sugar monitoring results.
- The duration of treatment with Verifica M 50/850 mg Tablet will depend on individual response and treatment goals.
- Regular follow-up appointments are necessary to assess the effectiveness and safety of Verifica M 50/850 mg Tablet.
- Do not crush or chew the tablet; swallow it whole for optimal absorption.
- If a dose is missed, take it as soon as remembered unless it's close to the next scheduled dose; do not double up on doses.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables while using Verifica M 50/850 mg Tablet.
- Engage in regular physical activity to enhance the effectiveness of this medication in controlling blood sugar levels.
- Monitor blood glucose levels regularly to assess the effectiveness of Verifica M 50/850 mg Tablet and make necessary adjustments with your healthcare provider.
- Avoid skipping meals to prevent fluctuations in blood sugar levels while on Verifica M 50/850 mg Tablet.
- Stay hydrated by drinking plenty of water throughout the day, especially when taking this medication.
Safety Advice
Side Effects
- Common side effects of Verifica M 50/850 mg Tablet include nausea and dizziness as the body adjusts to the medication.
- Some patients may experience headaches or tremors while taking Verifica M 50/850 mg Tablet.
- Weight gain can occur in some individuals using this medication; monitoring weight is advised.
- Hypoglycemia (low blood sugar) may happen, especially if combined with other antidiabetic agents.
- Serious side effects include lactic acidosis, characterized by symptoms such as deep or rapid breathing and persistent nausea; seek immediate medical attention if these occur.
- Consult a healthcare provider if side effects persist or worsen over time while using Verifica M 50/850 mg Tablet.
Precautions and Warnings
- Individuals with a known allergy to Metformin or Vildagliptin should avoid using Verifica M 50/850 mg Tablet.
- This medication is contraindicated in patients with severe kidney impairment or liver disease.
- Pregnant or breastfeeding women should consult their doctor before using Verifica M 50/850 mg Tablet.
- Avoid alcohol consumption while taking Verifica M 50/850 mg Tablet due to the increased risk of lactic acidosis.
- Regular monitoring of kidney function is essential during treatment with Verifica M 50/850 mg Tablet.
- Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.
- If experiencing symptoms like abdominal pain or jaundice, seek medical advice promptly while on Verifica M 50/850 mg Tablet.
FAQs
Verifica M 50/850 mg Tablet is primarily used for managing Type 2 diabetes mellitus by controlling blood sugar levels.
2. How should I take Verifica M 50/850 mg Tablet?
It is recommended to take Verifica M 50/850 mg Tablet orally with food to minimize gastrointestinal discomfort.
3. What are the common side effects of Verifica M 50/850 mg Tablet?
Common side effects include nausea, dizziness, headaches, and potential weight gain.
4. Can I drink alcohol while taking Verifica M 50/850 mg Tablet?
It is advisable to avoid alcohol consumption while taking Verifica M 50/850 mg Tablet due to the risk of lactic acidosis.
5. Who should avoid using Verifica M 50/850 mg Tablet?
Individuals with severe kidney impairment or liver disease should not use Verifica M 50/850 mg Tablet.
6. How does Verifica M 50/850 mg Tablet work?
Verifica M 50/850 mg Tablet works by combining Metformin and Vildagliptin to lower blood sugar levels through different mechanisms.
7. What should I do if I miss a dose of Verifica M 50/850 mg Tablet?
If you miss a dose of Verifica M 50/850 mg Tablet, take it as soon as you remember unless it's close to your next scheduled dose.
Instructions
Directions for Use
Storage and Disposal
- Store in a cool, dry place below 30°C.
- Protect from moisture and direct sunlight.
- Keep out of reach of children.
- Dispose of unused medicine per local regulations.
More Information
| SKU | 401423 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Lupin Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage |
|
| Seller | Kogland Commerce Pvt Ltd (TN) |
Verifica M 50/850 mg Tablet is a specialized pharmaceutical formulation designed for the management of Type 2 diabetes mellitus. This medication combines two active ingredients, Metformin and Vildagliptin, which work synergistically to control blood sugar levels effectively. The key composition of Verifica M 50/850 mg Tablet includes 50 mg of Vildagliptin and 850 mg of Metformin, making it a potent option for patients struggling with diabetes management. The primary purpose of Verifica M 50/850 mg Tablet is to improve glycemic control in adults with Type 2 diabetes, particularly when diet and exercise alone are insufficient. As part of the therapeutic category of antidiabetic medications, Verifica M 50/850 mg Tablet plays a crucial role in enhancing insulin sensitivity and reducing hepatic glucose production. By incorporating Verifica M 50/850 mg Tablet into their treatment regimen, patients can experience better overall health outcomes and a reduced risk of diabetes-related complications. This combination therapy not only helps in managing blood sugar levels but also supports weight management, making it an ideal choice for many individuals with Type 2 diabetes. The unique formulation of Verifica M 50/850 mg Tablet allows for improved patient adherence due to its once-daily dosing schedule, which simplifies the treatment process. Overall, Verifica M 50/850 mg Tablet represents a significant advancement in diabetes care, providing patients with an effective tool to manage their condition and improve their quality of life.
- Verifica M 50/850 mg Tablet effectively lowers blood sugar levels in patients with Type 2 diabetes.
- This formulation helps improve insulin sensitivity, making it easier for the body to utilize glucose.
- Verifica M 50/850 mg Tablet aids in reducing hepatic glucose production, contributing to better glycemic control.
- Patients using Verifica M 50/850 mg Tablet may experience fewer episodes of hypoglycemia compared to other diabetes medications.
- Verifica M 50/850 mg Tablet supports weight management, which is beneficial for individuals with Type 2 diabetes.
- This medication can be used in conjunction with diet and exercise to enhance overall diabetes management.
- Verifica M 50/850 mg Tablet is suitable for adults who require additional glycemic control beyond monotherapy.
- Regular use of Verifica M 50/850 mg Tablet can help prevent long-term complications associated with uncontrolled diabetes.
- Verifica M 50/850 mg Tablet is often prescribed when other medications have not achieved desired blood sugar levels.
- This combination therapy is designed to provide comprehensive management of Type 2 diabetes.
- Verifica M 50/850 mg Tablet can improve overall metabolic health by addressing insulin resistance.
- Patients may find that Verifica M 50/850 mg Tablet enhances their quality of life by stabilizing energy levels throughout the day.
Verifica M 50/850 mg Tablet works through a dual mechanism of action that targets different aspects of glucose metabolism. The combination of Metformin and Vildagliptin provides a comprehensive approach to managing blood sugar levels effectively.
- Metformin decreases hepatic glucose production, which helps lower blood sugar levels.
- This medication enhances insulin sensitivity in peripheral tissues, allowing for better glucose uptake.
- Vildagliptin increases the levels of incretin hormones, which stimulate insulin secretion in response to meals.
- The formulation reduces glucagon secretion, further aiding in blood sugar regulation.
- By combining these two mechanisms, Verifica M 50/850 mg Tablet provides more effective glycemic control than either drug alone.
- This dual-action approach minimizes the risk of hypoglycemia while promoting weight stability.
- Verifica M 50/850 mg Tablet should be taken orally with food to minimize gastrointestinal discomfort.
- The recommended dosage is typically one tablet daily, but this may vary based on individual needs and physician recommendations.
- It is essential to take Verifica M 50/850 mg Tablet at the same time each day to maintain consistent blood sugar control.
- Patients should follow their healthcare provider's instructions regarding dosage adjustments based on blood sugar monitoring results.
- The duration of treatment with Verifica M 50/850 mg Tablet will depend on individual response and treatment goals.
- Regular follow-up appointments are necessary to assess the effectiveness and safety of Verifica M 50/850 mg Tablet.
- Do not crush or chew the tablet; swallow it whole for optimal absorption.
- If a dose is missed, take it as soon as remembered unless it's close to the next scheduled dose; do not double up on doses.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables while using Verifica M 50/850 mg Tablet.
- Engage in regular physical activity to enhance the effectiveness of this medication in controlling blood sugar levels.
- Monitor blood glucose levels regularly to assess the effectiveness of Verifica M 50/850 mg Tablet and make necessary adjustments with your healthcare provider.
- Avoid skipping meals to prevent fluctuations in blood sugar levels while on Verifica M 50/850 mg Tablet.
- Stay hydrated by drinking plenty of water throughout the day, especially when taking this medication.
Side Effects
- Common side effects of Verifica M 50/850 mg Tablet include nausea and dizziness as the body adjusts to the medication.
- Some patients may experience headaches or tremors while taking Verifica M 50/850 mg Tablet.
- Weight gain can occur in some individuals using this medication; monitoring weight is advised.
- Hypoglycemia (low blood sugar) may happen, especially if combined with other antidiabetic agents.
- Serious side effects include lactic acidosis, characterized by symptoms such as deep or rapid breathing and persistent nausea; seek immediate medical attention if these occur.
- Consult a healthcare provider if side effects persist or worsen over time while using Verifica M 50/850 mg Tablet.
Precautions and Warnings
- Individuals with a known allergy to Metformin or Vildagliptin should avoid using Verifica M 50/850 mg Tablet.
- This medication is contraindicated in patients with severe kidney impairment or liver disease.
- Pregnant or breastfeeding women should consult their doctor before using Verifica M 50/850 mg Tablet.
- Avoid alcohol consumption while taking Verifica M 50/850 mg Tablet due to the increased risk of lactic acidosis.
- Regular monitoring of kidney function is essential during treatment with Verifica M 50/850 mg Tablet.
- Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.
- If experiencing symptoms like abdominal pain or jaundice, seek medical advice promptly while on Verifica M 50/850 mg Tablet.
Verifica M 50/850 mg Tablet is primarily used for managing Type 2 diabetes mellitus by controlling blood sugar levels.
2. How should I take Verifica M 50/850 mg Tablet?
It is recommended to take Verifica M 50/850 mg Tablet orally with food to minimize gastrointestinal discomfort.
3. What are the common side effects of Verifica M 50/850 mg Tablet?
Common side effects include nausea, dizziness, headaches, and potential weight gain.
4. Can I drink alcohol while taking Verifica M 50/850 mg Tablet?
It is advisable to avoid alcohol consumption while taking Verifica M 50/850 mg Tablet due to the risk of lactic acidosis.
5. Who should avoid using Verifica M 50/850 mg Tablet?
Individuals with severe kidney impairment or liver disease should not use Verifica M 50/850 mg Tablet.
6. How does Verifica M 50/850 mg Tablet work?
Verifica M 50/850 mg Tablet works by combining Metformin and Vildagliptin to lower blood sugar levels through different mechanisms.
7. What should I do if I miss a dose of Verifica M 50/850 mg Tablet?
If you miss a dose of Verifica M 50/850 mg Tablet, take it as soon as you remember unless it's close to your next scheduled dose.
Directions for Use
Storage and Disposal
- Store in a cool, dry place below 30°C.
- Protect from moisture and direct sunlight.
- Keep out of reach of children.
- Dispose of unused medicine per local regulations.
| SKU | 401423 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Lupin Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage |
|
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account